Skip to main content
Fig. 6 | Cardiovascular Diabetology

Fig. 6

From: A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control

Fig. 6

Relationship between haemoglobin (Hb)A1c and collagen-induced maximum platelet aggregation (maxPA) responses when receiving aspirin 75 mg or 300 mg once daily (OD), presented by HbA1c tertile (T) (panel A, p values shown for controls vs. tertile) and as receiver operating characteristic curves for predicting poor response to aspirin (panel B)

Back to article page